Anna Aranzullo, APRN
Nurse Practitioner · Easton, CTNPI 1619623725
Payments from drug & device makers
Across 28 payments — averaging $19.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$140
- Novo Nordisk$100
- Dexcom, Inc.$83
- AstraZeneca$62
- Boehringer Ingelheim$27
- Amgen$25
- plus $120 from 6 others
What the payments were for
- Food & beverage$54698%
- Education$122%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 8 | $140 |
| Novo Nordisk | 5 | $100 |
| Dexcom, Inc. | 4 | $83 |
| AstraZeneca | 3 | $62 |
| Boehringer Ingelheim | 1 | $27 |
| Amgen | 1 | $25 |
| Amryt Pharma Holdings Ltd | 1 | $25 |
| Sanofi-aventis U.S. LLC | 1 | $23 |
| Insulet Corporation | 1 | $20 |
| Acerus Pharmaceuticals Corporation | 1 | $19 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
| Alkermes, Inc. | 1 | $16 |
How this compares
$557 in reported general payments places this provider in the 80th percentile of 1,162 nurse practitioner providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 211 | $379,867 |
| TrulicityDulaglutide | 151 | $275,352 |
| JardianceEmpagliflozin | 153 | $219,210 |
| MounjaroTirzepatide | 105 | $172,373 |
| Tresiba Flextouch U-200Insulin Degludec | 44 | $71,047 |
| Tresiba Flextouch U-100Insulin Degludec | 80 | $63,424 |
| JanuviaSitagliptin Phosphate | 32 | $41,957 |
| TradjentaLinagliptin | 34 | $41,951 |
| FarxigaDapagliflozin Propanediol | 36 | $39,081 |
| RybelsusSemaglutide | 19 | $37,192 |
| Humalog Kwikpen U-100Insulin Lispro | 101 | $32,304 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 184 | $25,843 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 47 | $25,188 |
| Novolog FlexpenInsulin Aspart | 87 | $21,790 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 153 | $20,679 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro, Baqsimi, Humalog | $140 | $458,977284 claims |
| Novo NordiskOzempic, Rybelsus, Novolog | $100 | $425,351254 claims |
| Boehringer IngelheimJardiance, Tradjenta | $27 | $261,162187 claims |
| AstraZenecaFarxiga | $62 | $39,08136 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,162 nurse practitioner providers in Connecticut.
Other nurse practitioner in Easton
- Lindita VincaCheshire$427K
- Catherine MilnePlymouth$361K
- Michele NovellaDanbury$331K
- Tiffany RydzNewtown$49K
- Paul FidrychNorwich$23K
- Priscilla QuilterNorwich$21K
- Kimberly BoldonMiddletown$19K
- Emma RobinsonStamford$17K
- Janice TavaresBridgeport$17K
- Kelly WilberWaterbury$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.